134th Annual Shattuck Lecture - Challenges to the Future of a Robust Medical Workforce in the US
Tuesday, September 10, 2024, 7:00 to 8:00 p.m. EST
Live In-Person & Virtual
Brigham and Women's Hospital
Bornstein Family Amphitheater
45 Francis Street, 2nd Floor
Boston, MA 02115
Click here for directions
Rochelle P. Walensky, MD, MPH
Dr. Rochelle Walensky served as the 19th Director of the Centers for Disease Control and Prevention (2021-23), Professor of Medicine, Harvard Medical School (2012-2021), and Chief of the Division of Infectious Diseases, Massachusetts General Hospital
(2017-2021). Dr. Walensky is an infectious disease clinician whose research career is guided by a belief that the clinical and economic outcomes of medical decisions can be improved through the explicit articulation of choices, the systematic assembly
of evidence, and the careful assessment of comparative costs and benefits. She has focused these beliefs on mathematical model-based research toward the promotion of global access to HIV prevention, screening, and care. Her ground-breaking work and
over 300 research publications have motivated changes to US HIV testing and immigration policy; promoted expanded funding for HIV-related research, treatment, and the President's Emergency Plan for AIDS Relief (PEPfAR); and led to policy revisions
toward aggressive HIV screening – especially for the underserved – and earlier treatment in resource-limited international settings. In light of these contributions, Dr. Walensky has been an active member of policy discussions at the WHO, UNAIDS,
the DHHS HIV Guidelines Committee, and the NIH Office of AIDS Research. She is a member of the National Academy of Medicine and the Council on Foreign Relations.
Dr. Walensky served on the frontlines of the COVID-19 pandemic in Massachusetts until beginning her tenure at the CDC on January 20th, 2021. While at the CDC, Dr. Walensky led the nation - and the world - through unprecedented times, navigating the darkest
days of the COVID-19 pandemic and further facing the largest density of diverse infectious threats likely ever seen in this country. During her tenure, she participated in nearly 100 press conferences and countless media appearances, and provided
testimony at 17 Congressional hearings.
Dr. Walensky received her BA (Biochemistry and Molecular Biology, 1991) from Washington University in St. Louis; her MD from the Johns Hopkins School of Medicine (1995) and her MPH from the Harvard School of Public Health (Clinical Effectiveness, 2001).
She completed her Internal Medicine residency at the Johns Hopkins Hospital (1995-1998) and her Infectious Disease fellowship at the Massachusetts General/Brigham and Women’s Hospital combined program (1998-2001). She is married to Loren Walensky,
MD, PhD, a physician-scientist and pediatric oncologist at the Dana-Farber Cancer Institute/Boston Children’s Hospital. The Doctors Walensky have 3 sons ages 20, 22, and 24.
Eric J. Rubin, MD, MPH
Eric J. Rubin, M.D., Ph.D., is Editor-in-Chief of the New England Journal of Medicine (NEJM), the world’s most widely read and oldest continuously published medical periodical, and NEJM Group, the publishing division of the Massachusetts Medical
Society. In addition to overseeing all editorial content and policies at NEJM Group, Dr. Rubin is a tuberculosis researcher and infectious disease physician.
Joining NEJM as an Associate Editor in 2012, Dr. Rubin was appointed Editor-in-Chief in September 2019. He led the Journal through the height of the COVID-19 pandemic, mobilizing NEJM editors and staff to rapidly publish lifesaving research that
was triple the standard volume of publication. In addition, he was instrumental in the launch of a weekly podcast covering scientific and public health developments about the disease.
Under his editorial leadership, NEJM Group launched NEJM Evidence (2022) and NEJM AI (2023), a new monthly journal that explores cutting-edge applications of artificial intelligence and machine learning in clinical medicine. He also oversees
NEJM Catalyst Innovations in Care Delivery, NEJM Journal Watch, and educational resources for medical students and residents.
Through podcasts, long-form videos, and multimedia content accessible on mobile devices, Dr. Rubin is focused on reaching authors, journal readers, and health professionals with trusted health evidence. He believes that NEJM has a fundamental responsibility
to build trust in science while communicating medical information that both new and experienced clinicians can act on immediately.
Dr. Rubin is a Professor of Medicine at Harvard Medical School and an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, training dozens of students and postdoctoral fellows. His lab studies the fundamental
biology of tuberculosis and how knowledge of that biology can be used to create new therapeutic approaches.
A frequent keynote speaker, Dr. Rubin has collaborated with international science and global health organizations such as the Gates Foundation and Wellcome. He serves on several scientific advisory boards for groups interested in infectious disease therapeutics,
including the National Institutes of Health, the Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration, the Global Alliance for TB Drug Development, and the Sub-Saharan African Network for TB/HIV Research
Excellence.
As an Associate Physician specializing in infectious diseases, he sees patients at Brigham and Women’s Hospital in Boston. Dr. Rubin is member of several professional organizations including the National Academy of Medicine. A native of Brockton, Massachusetts,
Dr. Rubin earned a Bachelor of Arts degree from Harvard College, an MD from Tufts University School of Medicine, and a PhD from Tufts University.
